HSPE1 and cancer: Hence, our data suggest that monitoring Hsp60 and Hsp10 levels in patients with COPD could help in the identification of a subclass of patients (i.e., those in which Hsp60 and Hsp10 levels suddenly decrease) which would have a higher risk for cancer development.